Showing results (861-870 of 3,921) with videos related to
Sort By:
Pageof 393
European Journal of Gynaecological Oncology|April 5, 2008
Risk factors for cervical cancer in China: a case-control studyH B Cai, X H Ding, Y F Zhou, et al.European Journal of Gynaecological Oncology|April 5, 2008
Relationship between risk factors and tumor stage in breast cancer patients in a university hospital--BrazilM A O Mendonça, B M Tavares-Murta, E S Bachin, et al.European Journal of Gynaecological Oncology|April 5, 2008
Recurrence of granulosa cell tumor 25 years after initial diagnosis. Report of a case and review of the literatureD Hasiakos, K Papakonstantinou, E Karvouni, et al.European Journal of Gynaecological Oncology|April 5, 2008
Endometrial metastasis of a primitive neuroendocrine ovarian carcinoma: management and treatment of a caseE Tartaglia, C Di Serio, M Rotondi, et al.European Journal of Gynaecological Oncology|January 1, 1989
Use of Cavitron Ultrasonic Surgical Aspirator (CUSA) for palliative resection of recurrent gynecologic malignancies involving the vaginaG Deppe, V K Malviya, J M MaloneEuropean Journal of Gynaecological Oncology|January 1, 1989
Endocervical adenocarcinoma. Clinico-pathologic and histochemical study of 29 casesL Resta, M D Scordari, R S Mastrogiulio, et al.European Journal of Gynaecological Oncology|January 1, 1988
Intraarterial infusion chemotherapy as a primary treatment in cancer of uterine cervix limited to the pelvisJ A Lejarcegui, X Cot, J M Lailla, et al.European Journal of Gynaecological Oncology|March 25, 2014
An evaluation of immune system cell infiltrate in the cervical stroma of patients with grade III cervical intraepithelial neoplasia after treatment with intralesional alpha-2B interferonF A Machado, D R Abdalla, L Montes, et al.European Journal of Gynaecological Oncology|March 25, 2014
The impact of epithelial ovarian cancer diagnosis on women's life: a qualitative studyL Mangone, V D Mandato, R Gandolfi, et al.European Journal of Gynaecological Oncology|March 25, 2014
Assessment of the tumor-associated trypsin inhibitor (TATI) marker in patients with carcinoma of the uterine body 17 years after treatmentB Kozakiewicz, M Chadzyńska, E Dmoch-GajzlerskaPageof 393